{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:19:49Z","timestamp":1767665989337},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ejphar.2015.03.032","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T14:10:35Z","timestamp":1428329435000},"page":"326-342","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The transferability from rat subacute 4-week oral toxicity study to translational research exemplified by two pharmaceutical immunosuppressants and two environmental pollutants with immunomodulating properties"],"prefix":"10.1016","volume":"759","author":[{"given":"Jessica","family":"Kemmerling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Fehlert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Frieke","family":"Kuper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"R\u00fchl-Fehlert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela","family":"Stropp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Vogels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrille","family":"Krul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Werner","family":"Vohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.03.032_bib1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1523-1747.2002.01709.x","article-title":"Localization of calcineurin\/NFAT in human skin and psoriasis and inhibition of calcineurin\/NFAT activation in human keratinocytes by cyclosporine A","volume":"118","author":"Al-Daraji","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0009-9120(00)00175-2","article-title":"New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine","volume":"34","author":"Armstrong","year":"2001","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejphar.2015.03.032_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.toxlet.2012.08.020","article-title":"Multiparametric immunotoxicity screening in mice during early drug development","volume":"214","author":"Aul\u00ed","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2015.03.032_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2249.1993.tb08179.x","article-title":"The anti-arthritic and immunosuppressive effects of cyclosporin A on collagen-induced arthritis in the rhesus monkey","volume":"93","author":"Bakker","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2000.tb01004.x","article-title":"Neurotoxicity of calcineurin inhibitors: impact and clinical management","volume":"13","author":"Bechstein","year":"2000","journal-title":"Transpl. Int."},{"key":"10.1016\/j.ejphar.2015.03.032_bib6","unstructured":"BgVV Hefte, Federal Institute for Health Protection of Consumers and Veterinary Medicine, 04\/1996. Evaluation of the Appropriateness of the extended subacute (28 day-) toxicity test to detwect adverse effects on the immune system. ISBN 3-931675-06-8."},{"key":"10.1016\/j.ejphar.2015.03.032_bib7","unstructured":"BgVV Hefte, Federal Institute for Health Protection of Consumers and Veterinary Medicine. In: Schulte, A., Althoff, J., Ewe, S., Richter-Reichhelm, H.B., 04\/2000. Screening for Immunotoxic Effects \u2013 Ring Study with Hexachlorobenzene Based on the Enhanced OECD Test Guideline 407, vols. I and II. ISBN 3-931675-62-9."},{"key":"10.1016\/j.ejphar.2015.03.032_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0300-483X(97)00154-6","article-title":"Effect of pentachlorophenol on immune function","volume":"125","author":"Blakley","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2125.1996.34412.x","article-title":"Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients","volume":"41","author":"Bleck","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0300-483X(94)90041-8","article-title":"Immune parameters are affected differently after cyclosporine A exposure in Fischer 344 rats and B6C3F1 mice: implications for immunotoxicology","volume":"94","author":"Blot","year":"1994","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbi.2007.07.012","article-title":"Stressor-specific alterations in corticosterone and immune responses in mice","volume":"22","author":"Bowers","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2015.03.032_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4757-9182-2_24","article-title":"Induction of an humoral and cellular (auto) immune response to human and rat myeloperoxidase (MPO) in Brown-Norway (BN), Lewis and Wistar Kyoto (WKY) rat strains","volume":"336","author":"Brouwer","year":"1993","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib13","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/1073161X.1993.10467179","article-title":"Assessment of carcinogenic risk from personal exposure to benzo(a)pyrene in the total humal environment exposure study (THEES)","volume":"43","author":"Butler","year":"1993","journal-title":"J. Air Waste Manag. Assoc."},{"key":"10.1016\/j.ejphar.2015.03.032_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/019262338701500310","article-title":"The immunopharmacology of immunotoxicology, and immunorestoration","volume":"15","author":"Caspritz","year":"1987","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tox.2006.09.003","article-title":"In vitro tests to evaluate immunotoxicity: a preliminary study","volume":"229","author":"Carfi","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib16","series-title":"Encyclopedic Reference of Immunotoxicology","first-page":"469","article-title":"Natural killer cell assay","author":"Cederbrant","year":"2005"},{"key":"10.1016\/j.ejphar.2015.03.032_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2217\/pgs.14.32","article-title":"Interindividual variability in TPMT enzyme activity: 10 years of experience with thiopurine pharmacogenetics and therapeutic drug monitoring","volume":"15","author":"Chouchana","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejphar.2015.03.032_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/scisignal.3143pe36","article-title":"Stress and sex versus immunity and inflammation","volume":"3","author":"Chrousos","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejphar.2015.03.032_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.transproceed.2004.01.054","article-title":"Evolution of the therapeutic drug monitoring of cyclosporine","volume":"36","author":"Citterio","year":"2004","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejphar.2015.03.032_bib20","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.1118355109","article-title":"Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk","volume":"109","author":"Cohen","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2015.03.032_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2012.10.009","article-title":"Pesticide induced immunotoxicity in humans: a comprehensive review of the existing evidence","volume":"307","author":"Corsini","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10637-005-4020-8","article-title":"The thiopurines: an update","volume":"23","author":"Coulthard","year":"2005","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ejphar.2015.03.032_bib23","series-title":"Encyclopedic reference of immunotoxicology","first-page":"401","article-title":"Lymphocyte proliferation","author":"Crevel","year":"2005"},{"key":"10.1016\/j.ejphar.2015.03.032_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1749-6632.1998.tb09575.x","article-title":"Stress-induced enhancement of cell-mediated immunity","volume":"840","author":"Dabhar","year":"1998","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ejphar.2015.03.032_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/toxsci\/50.2.214","article-title":"Detection of immunotoxicity of Benzo[a]pyrene in a subacute toxicity study after oral exposure in rats","volume":"50","author":"De Jong","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2015.03.032_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/rtph.1995.1047","article-title":"Investigation of a screening battery for immunotoxicity of pharmaceuticals within a 28-day oral toxicity study using azathioprine and cyclosporin A as model compounds","volume":"21","author":"De Waal","year":"1995","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0041-008X(78)80038-6","article-title":"Hexachlorobenzene toxicity in pigs","volume":"43","author":"Den Tonkelaar","year":"1978","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0300-483X(96)03407-5","article-title":"Extension of the 4-week safety study for detecting immune system impairment appears not necessary: example of cyclosporine A in rats","volume":"112","author":"Descotes","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vascn.2012.05.001","article-title":"Safety immunopharmacology: evaluation of the adverse potential of pharmaceuticals on the immune system","volume":"66","author":"Descotes","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2015.03.032_bib30","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.psyneuen.2012.05.008","article-title":"Stress-induced redistribution of immune cells-from barracks to boulevards to battlefields: a tale of three hormones \u2013 Curt Richter Award winner","volume":"37","author":"Dhabhar","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib31","first-page":"373","article-title":"Comparative bioavailability and pharmacokinetic studies of azathioprine and 6-mercaptopurine in the rhesus monkey","volume":"7","author":"Ding","year":"1979","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2015.03.032_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.ftd.0000169061.52715.3e","article-title":"Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides","volume":"27","author":"Duley","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2015.03.032_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0192623311427571","article-title":"Enhanced histopathology of the immune system: a review and update","volume":"40","author":"Elmore","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib35","unstructured":"European Agency for the Evaluation of Medicinal Products EM(E)A, 2000. CPMP\/SWP\/1042\/99 corr. Note for guidance on repeated dose toxicity. Available from: \u3008http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003102.pdf\u3009 (last accessed 03.12.14)."},{"key":"10.1016\/j.ejphar.2015.03.032_bib36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/0192623312466452","article-title":"Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment","volume":"41","author":"Everds","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib37","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/tx034016p","article-title":"Immunomodulatory effects of tetrahydrobenzoquinone, a reactive metabolite of hexachlorobenzene","volume":"16","author":"Ezendam","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/toxsci\/kfh034","article-title":"Hexachlorobenzene-induced immunopathology in Brown Norway rats is partly mediated by T-cells","volume":"78","author":"Ezendam","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2015.03.032_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.taap.2005.03.010","article-title":"Macrophages are involved in hexachlorobenzene-induced adverse immune effects","volume":"209","author":"Ezendam","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib40","first-page":"153","article-title":"Effects of cyclosporin A on mouse thymus: immunochemical and ultrastructural studies","volume":"20","author":"Fabien","year":"1992","journal-title":"Thymus"},{"key":"10.1016\/j.ejphar.2015.03.032_bib41","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.tiv.2011.06.020","article-title":"Specific antibody responses of primary cells from different cell sources are able to predict immunotoxicity in vitro","volume":"25","author":"Fischer","year":"2011","journal-title":"Toxicol. in vitro"},{"key":"10.1016\/j.ejphar.2015.03.032_bib42","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/ajpcell.00537.2002","article-title":"Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurin-dependent activation of NFAT in follicular keratinocytes","volume":"284","author":"Gafter-Gwili","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/1547691X.2010.509848","article-title":"Present and future of in vitro immunotoxicology in drug development","volume":"7","author":"Galbiati","year":"2010","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib44","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1440-1746.2005.03832.x","article-title":"Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprine","volume":"20","author":"Gearry","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/10408444.2014.882291","article-title":"Retrospective evaluation of the impact of functional testing on pesticide hazard identification and risk assessment","volume":"44","author":"Gehen","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib46","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1023\/A:1005573229786","article-title":"Sequential group trial to determine gastrointestinal site of absorption and systemic exposure of azathioprine","volume":"45","author":"Gervasio","year":"2000","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2015.03.032_bib47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s004150050360","article-title":"Cyclosporine neurotoxicity: a review","volume":"246","author":"Gijtenbeek","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0041-008X(77)90093-X","article-title":"Toxic effects of hexachlorobenzene after daily administration to beagle dogs for one year","volume":"40","author":"Gralla","year":"1977","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib49","series-title":"Encyclopedic Reference of Immunotoxicology","first-page":"612","article-title":"Stress and the immune system","author":"Haggerty","year":"2005"},{"key":"10.1016\/j.ejphar.2015.03.032_bib50","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/01926230590934304","article-title":"STP position paper: best practice guideline for the routine pathology evaluation of the immune system","volume":"33","author":"Haley","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.14573\/altex.2013.4.411","article-title":"Immunotoxicology: challenges in the 21st century and in vitro oppurtunities","volume":"30","author":"Hartung","year":"2013","journal-title":"ALTEX"},{"key":"10.1016\/j.ejphar.2015.03.032_bib52","first-page":"111","article-title":"Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine","volume":"128","author":"Hattori","year":"1987","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib53","unstructured":"HCN, Health Council of the Netherlands, 2011. Dutch Expert Committee on Occupational Safety. Health-Based Recommended Occupational Exposre Limit. Hexachlorobenzene. Available from: \u3008http:\/\/www.gr.nl\/sites\/default\/files\/201135Hexachlorobenzene.pdf\u3009 (last accessed 07.09. 14)."},{"key":"10.1016\/j.ejphar.2015.03.032_bib54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bcp.2008.09.030","article-title":"Aryl hydrocarbon receptor biology and xenobiotic responses in hematopoietic progenitor cells","volume":"77","author":"Hirabashi","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/clin.1996.0140","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"80","author":"Ho","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5301\/jn.5000174","article-title":"Pathogenesis of calcineurin inhibitor-induced hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib57","first-page":"1","article-title":"Some antineoplastic and immunosuppressive agents","volume":"26","author":"IARC","year":"1981","journal-title":"IARC Monogr. Eval. Carcinog. Risk Chem. Hum."},{"key":"10.1016\/j.ejphar.2015.03.032_bib58","first-page":"1","article-title":"Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42","volume":"7","author":"IARC","year":"1987","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum. Suppl."},{"key":"10.1016\/j.ejphar.2015.03.032_bib59","first-page":"493","article-title":"Hexachlorobenzene. In some thyrotropic agents","volume":"79","author":"IARC","year":"2001","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.ejphar.2015.03.032_bib60","first-page":"319","article-title":"A review of human carcinogens: pharmaceuticals","volume":"100A","author":"IARC","year":"2012","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.ejphar.2015.03.032_bib61","first-page":"111","article-title":"Chemical agents and related occupations","volume":"100F","author":"IARC","year":"2012","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.ejphar.2015.03.032_bib62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0041-008X(76)90205-2","article-title":"Morphological effects of hexachlorobenzene toxicity in female rhesus monkeys","volume":"37","author":"Iatropoulos","year":"1976","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib63","unstructured":"ICH S6(R1) Guideline: Preclinical safety evaluation of biotechnology-derived pharmaceuticals, June 2011. Available from: \u3008http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Safety\/S6_R1\/Step4\/S6_R1_Guideline.pdf\u3009 (last accessed 02.12. 14)."},{"key":"10.1016\/j.ejphar.2015.03.032_bib64","unstructured":"ICH S8 Guideline: Immunotoxicity studies for human pharmaceuticals, 15.09.2005. Available from: \u3008http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Safety\/S8\/Step4\/S8_Guideline.pdf\u3009 (last accessed 02.12. 14)."},{"key":"10.1016\/j.ejphar.2015.03.032_bib65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s002800050873","article-title":"Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens","volume":"43","author":"Innocenti","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0300-483X(97)00166-2","article-title":"Report of validation study of assessment of direct immunotoxicity in the rat","volume":"125","author":"International Collaborative Immunotoxicity Study (ICISIS) Group Investigators","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib67","first-page":"534","article-title":"Effects of cyclosporin A on mouse lymphoid tissues","volume":"64","author":"Kai","year":"1983","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.transproceed.2004.01.018","article-title":"Pharmacology of calcineurin antagonists","volume":"36","author":"Kapturczak","year":"2004","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ejphar.2015.03.032_bib69","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.toxlet.2013.06.236","article-title":"Cyclosporine A treated in vitro models induce cholestasis response through comparison of phenotype-directed gene expression analysis of in vivo Cyclosporine A-induced cholestasis","volume":"221","author":"Kienhuis","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2015.03.032_bib70","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/bmj.2.6203.1461","article-title":"Collaborative United Kingdom\u2013Australasian study of cancer in patients treated with immunosuppressive drugs","volume":"2","author":"Kinlen","year":"1979","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2015.03.032_bib71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","article-title":"Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment","volume":"78","author":"Kinlen","year":"1985","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2015.03.032_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1749-6632.2002.tb04140.x","article-title":"Assessment of protein allergenicity: studies in brown norway rats","volume":"964","author":"Knippels","year":"2002","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ejphar.2015.03.032_bib73","series-title":"Cyclosporin A-Induced Hyperlipidemia, Lipoproteins \u2013 Role in Health and Diseases","isbn-type":"print","author":"Kockx","year":"2012","ISBN":"http:\/\/id.crossref.org\/isbn\/9789535107736"},{"key":"10.1016\/j.ejphar.2015.03.032_bib74","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.fct.2008.10.025","article-title":"Functional assays are mandatory for a correct prediction of immunosppressant properties of compounds in vitro","volume":"47","author":"Koeper","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib75","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0041-008X(77)90078-3","article-title":"Subacute toxicity of hexachlorobenzene in the rat","volume":"40","author":"Kuiper-Goodman","year":"1977","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"10.1016\/j.ejphar.2015.03.032_bib76","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/019262330002800317","article-title":"Histopathologic approaches to detect changes indicative of immunotoxicity","volume":"28","author":"Kuper","year":"2000","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib77","series-title":"Handbook of Toxicologic Pathology","isbn-type":"print","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/B978-0-12-415759-0.00049-2","article-title":"Immune system","author":"Kuper","year":"2013","ISBN":"http:\/\/id.crossref.org\/isbn\/9780124157590"},{"key":"10.1016\/j.ejphar.2015.03.032_bib78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0300-483X(94)02967-Y","article-title":"Possible incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats on standard toxicology study","volume":"96","author":"Ladics","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib79","first-page":"253","article-title":"Polychlorinated biphenyl and hexachlorobenzene induced humoral immunosuppression","volume":"22","author":"Loose","year":"1977","journal-title":"J. Reticuloendothel. Soc."},{"key":"10.1016\/j.ejphar.2015.03.032_bib80","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.0105-2896.2004.0112.x","article-title":"Development and selection of marginal zone B cells","volume":"197","author":"Lopes-Carvalho","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2015.03.032_bib81","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/0192623311427572","article-title":"Immunotoxicant screening and prioritization in the twenty-first century","volume":"40","author":"Luebke","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib82","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0272-0590(92)90047-L","article-title":"Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests","volume":"18","author":"Luster","year":"1992","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/faat.1993.1074","article-title":"Risk assessment in immunotoxicology. II. Relationship between immune and host resistance tests","volume":"21","author":"Luster","year":"1993","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib84","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2004-06-2410","article-title":"Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide","volume":"105","author":"Lutsiak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.03.032_bib85","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI200318384","article-title":"Azathioprine: old drug, new actions","volume":"111","author":"Maltzman","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2015.03.032_bib86","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-200403000-00006","article-title":"Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)","volume":"14","author":"Marinaki","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ejphar.2015.03.032_bib87","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/01926230600978474","article-title":"Enhanced histopathology of lymphoid tissues","volume":"34","author":"Maronpot","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib88","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/taap.1997.8104","article-title":"Hexachlorobenzene-induced immunomodulation and skin and lung lesions: a comparison between Brown Norway, Lewis and Wistar rats","volume":"144","author":"Michielsen","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib89","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1289\/ehp.99107s5783","article-title":"The role of the immune system in hexachlorobenzene-lnduced toxicity","volume":"107","author":"Michielsen","year":"1999","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejphar.2015.03.032_bib90","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00204-002-0326-x","article-title":"The environmental pollutant hexachlorobenzene causes eosinophilic and granulomatous inflammation and in vitro airways hyperreactivity in the Brown Norway rat","volume":"76","author":"Michielsen","year":"2002","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib91","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.transproceed.2004.01.025","article-title":"Therapeutic drug monitoring of cyclosporine","volume":"36","author":"Midtvedt","year":"2004","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ejphar.2015.03.032_bib92","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1067\/mcp.2000.111255","article-title":"Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers","volume":"68","author":"Min","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2015.03.032_bib93","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2217\/pgs.14.87","article-title":"Calcineurin inhibitors and hypertension: a role for pharmacogenetics?","volume":"15","author":"Moes","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejphar.2015.03.032_bib94","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2613.2008.00575.x","article-title":"The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse","volume":"89","author":"Molyneux","year":"2008","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib95","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosman","year":"1983","journal-title":"J. Immunol. Method"},{"key":"10.1016\/j.ejphar.2015.03.032_bib96","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1373\/clinchem.2011.167296","article-title":"Molecular diagnostics of calcineurin-related pathologies","volume":"58","author":"Musson","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2015.03.032_bib97","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/mol.113.086637","article-title":"Oral benzo[a]pyrene: understanding pharmacokinetics, detoxication, and consequences-Cyp1 knockout mouse lines as a paradigm","volume":"84","author":"Nebert","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/vr.102471","article-title":"Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis","volume":"174","author":"Nuttall","year":"2014","journal-title":"Vet. Rec."},{"key":"10.1016\/j.ejphar.2015.03.032_bib99","series-title":"Guidelines for the Testing of Chemicals\/ No. 407: Repeated Dose Oral Toxicity Test Method","author":"OECD","year":"2008"},{"key":"10.1016\/j.ejphar.2015.03.032_bib100","first-page":"479","article-title":"Patterns of MHC antigenic modulation in cyclosporine-induced autoimmunity. Implications for pathogenesis","volume":"136","author":"Parfrey","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib101","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.toxlet.2004.04.023","article-title":"Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox","volume":"153","author":"Pestka","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2015.03.032_bib102","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.1987.tb48773.x","article-title":"Turkish epidemic hexachlorobenzene porphyria. A 30-year study","volume":"514","author":"Peters","year":"1987","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ejphar.2015.03.032_bib103","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/toxsci\/kfp073","article-title":"Patterns of immunotoxicity associated with chronic as compared with acute exposure to chemical or physical stressors and their relevance with regard to the role of stress and with regard to immunotoxicity testing","volume":"109","author":"Pruett","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2015.03.032_bib104","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/096032719701600605","article-title":"Defective neutrophil function in workers occupationally exposed to hexachlorobenzene","volume":"16","author":"Queiroz","year":"1997","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1191\/096032798678908477","article-title":"Immunoglobulin levels in workers exposed to hexachlorobenzene","volume":"17","author":"Queiroz","year":"1998","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib106","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/08923979809034826","article-title":"Polymorphonuclear phagocytosis and killing in workers occupationally exposed to hexachlorobenzene","volume":"20","author":"Queiroz","year":"1998","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib107","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.4049\/jimmunol.170.10.4986","article-title":"Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides","volume":"170","author":"Qu\u00e9m\u00e9neur","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib108","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/rtph.1995.1068","article-title":"Validation of a modified 28-day rat study to evidence effects of test compounds on the immune system","volume":"22","author":"Richter-Reichhelm","year":"1995","journal-title":"Reg. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib109","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0300-483X(98)00066-3","article-title":"Results of a cyclosporin A ringstudy","volume":"129","author":"Richter-Reichhelm","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/096032719501400126","article-title":"The immunotoxicity of pesticides in rodents","volume":"14","author":"Rodgers","year":"1995","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib111","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-3083.1998.00414.x","article-title":"Differential expression of T-cell adhesion moleculaes and LFA-1-dependent intercellular adhesion in HgCl2-induced autoimmunity and immune suppression","volume":"48","author":"Roos","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib112","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","article-title":"Clinical pharmacology and pharmacogenetics of thiopurines","volume":"64","author":"Sahasranaman","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib113","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/08923979409007099","article-title":"Induction of apoptosis in mouse thymocytes by cyclosporin A: in vivo study","volume":"16","author":"Saiagh","year":"1994","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib114","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4049\/jimmunol.142.2.471","article-title":"Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease","volume":"142","author":"Sakaguchi","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/00039899909602243","article-title":"Health effects of chronic high exposure to hexachlorobenzene in a general population sample","volume":"54","author":"Sala","year":"1999","journal-title":"Arch. Environ. Health"},{"key":"10.1016\/j.ejphar.2015.03.032_bib116","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.fpc.0000114745.08559.db","article-title":"Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants","volume":"14","author":"Schaeffeler","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ejphar.2015.03.032_bib117","article-title":"Detection of the mechanism of immunotoxicity of cyclosporine A in murine in vitro and in vivo models","author":"Schmeits","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib118","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/rtph.2002.1568","article-title":"Two immunotoxicity ring studies according to OECD TG 407 \u2013 comparison of data on cyclosporine A and hexachlorobenzene","volume":"36","author":"Schulte","year":"2002","journal-title":"Reg. Toxicol. Pharmacol."},{"issue":"Pt B","key":"10.1016\/j.ejphar.2015.03.032_bib119","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4757-0390-0_21","article-title":"Purine metabolism in human thymocyte subsets: relevance for lymphocytic differentiation","volume":"165","author":"Schuurman","year":"1984","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0300-483X(94)90004-3","article-title":"Histopathology of the immune system as a tool to assess immunotoxicity","volume":"86","author":"Schuurman","year":"1994","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib121","unstructured":"SCOEL, 2013. Recommendation from the Scientific Committee on Occupational Exposure Limits for Hexachlorobenzene. SCOEL\/SUM\/188. Draft for 6-month consultation. December 2013. Available from: \u3008http:\/\/www.ser.nl\/documents\/82398.pdf\u3009 (last accessed 07.09. 14)."},{"key":"10.1016\/j.ejphar.2015.03.032_bib122","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1037\/0033-2909.130.4.601","article-title":"Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry","volume":"130","author":"Segerstrom","year":"2004","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.ejphar.2015.03.032_bib123","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1289\/ehp.8139105","article-title":"Assessment of environmental contaminant-induced lymphocyte dysfunction","volume":"39","author":"Silkworth","year":"1981","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejphar.2015.03.032_bib124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ibd.20004","article-title":"Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease","volume":"13","author":"Stocco","year":"2007","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.ejphar.2015.03.032_bib125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0300-483X(97)00166-2","article-title":"Report of validation study of direct immunotoxicity in the rat","volume":"125","author":"The ICISIS Group Investigators","year":"1998","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.ejphar.2015.03.032_bib126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1172\/JCI200112173","article-title":"T cell homeostasis and systemic autoimmunity","volume":"108","author":"Theofilopoulos","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2015.03.032_bib127","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0378-4274(91)90093-L","article-title":"Studies on sex-differences in excreation of sulphur derivates of hexachlorobenzene and pentachloronitrobenzene in rats","volume":"56","author":"To-Figueras","year":"1990","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2015.03.032_bib128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1289\/ehp.9710578","article-title":"Metabolism of hexachlorobenzene in humans: association between serum levels and urinary metabolites in a highly exposed population","volume":"105","author":"To-Figueras","year":"1997","journal-title":"Environ. Health. Perspect."},{"key":"10.1016\/j.ejphar.2015.03.032_bib129","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/jcph.123","article-title":"Sex differences in cyclosporine pharmacokinetics and ABCB1 gene expression in mononuclear blood cells in African American and Caucasian renal transplant recipients","volume":"53","author":"Tornatore","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib130","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/mol.105.021501","article-title":"Oral benzo(a)pyrene in CYP 1 knockout mouse lines: CYP1A1 Important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate","volume":"69","author":"Uno","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib131","unstructured":"U.S. EPA, 1998. United States Environmental Protection Agency. Health Effects Test Guidelines: OPPTS 870.7800. Immunotoxicity. Available from: \u3008http:\/\/www.regulations.gov\/#!documentDetail;D=EPA-HQ-OPPT-2009-0156-0049\u3009 (last accessed 12.12. 14)."},{"key":"10.1016\/j.ejphar.2015.03.032_bib132","unstructured":"U.S. EPA, 2007. Benzo(a)pyrene. TEACH Chemical Summary. Available from: \u3008http:\/\/www.epa.gov\/teach\/teachsummaries.html\u3009 (last accessed 12.12. 14)."},{"key":"10.1016\/j.ejphar.2015.03.032_bib133","unstructured":"U.S. EPA, 2013. A retrospective analysis of immunotoxicity studies (870.7800). Available from: \u3008http:\/\/www2.epa.gov\/pesticide-registration\/retrospective-analysis-immunotoxicity-study\u3009 (last accessed 12.12. 14)."},{"key":"10.1016\/j.ejphar.2015.03.032_bib134","unstructured":"U.S. FDA, 1999. Guidance for Industry and reviewers. Immunotoxicity guidance. Available from: \u3008http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/ucm080495.htm\u3009 (last accessed 02.12.14)."},{"key":"10.1016\/j.ejphar.2015.03.032_bib135","unstructured":"U.S. FDA, 2002. Guidance for industry: Immunotoxicology evaluation of investigational new drugs. Available from: \u3008http:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/howdrugsaredevelopedandapproved\/approvalapplications\/investigationalnewdrugindapplication\/default.htm\u3009 (last accessed 12.12. 14)."},{"key":"10.1016\/j.ejphar.2015.03.032_bib136","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1289\/ehp.106-1533492","article-title":"Hexachlorobenzene as a possible major contributor to the dioxin activity of human milk","volume":"106","author":"Van Birgelen","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejphar.2015.03.032_bib137","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.taap.2005.02.030","article-title":"Current status and burning issues in immunotoxicity testing of drugs","volume":"207","author":"Van der Laan","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib138","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/gut.39.1.63","article-title":"Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration","volume":"39","author":"Van Os","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2015.03.032_bib139","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.gene.6364257","article-title":"Current status of genetics research in inflammatory bowel disease","volume":"6","author":"Vermeire","year":"2005","journal-title":"Genes Immun."},{"key":"10.1016\/j.ejphar.2015.03.032_bib140","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cvsm.2013.04.009","article-title":"Update on immununosuppressive therapies for dogs and cats","volume":"43","author":"Viviano","year":"2013","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.ejphar.2015.03.032_bib141","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0300-483X(95)03179-J","article-title":"Experiences with an advanced screening procedure for the identification of chemicals with an immunotoxic potential in routine toxicology","volume":"104","author":"Vohr","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2015.03.032_bib142","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0048-9697(00)00801-9","article-title":"Industry experience in the identification of the immunotoxic potential of agrochemicals","volume":"270","author":"Vohr","year":"2001","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ejphar.2015.03.032_bib143","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1749-6632.1979.tb13175.x","article-title":"Hexachlorobenzene-induced stimulation of the humoral immune response in rats","volume":"320","author":"Vos","year":"1979","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ejphar.2015.03.032_bib144","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/01480547908993182","article-title":"Effect of hexachlorobenzene on the immune system of rats following pre- and postnatal exposure","volume":"2","author":"Vos","year":"1979","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib145","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00007890-198511000-00004","article-title":"Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage","volume":"40","author":"Wassef","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/j.ejphar.2015.03.032_bib146","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.fct.2011.12.003","article-title":"Carcinogenic activity of benzo[a]pyrene in a 2 year oral study in Wistar rats","volume":"50","author":"Wester","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib147","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1748-5827.2011.01024.x","article-title":"Immunomodulatory drugs and their application to the management of canine immune-mediated disease","volume":"52","author":"Whitley","year":"2011","journal-title":"J. Small Anim. Pract."},{"key":"10.1016\/j.ejphar.2015.03.032_bib148","series-title":"Alternative Methods for Regulatory Toxicology \u2013 A State-of-the-Art Review. JRC Science and Policy Reports","author":"Worth","year":"2014"},{"key":"10.1016\/j.ejphar.2015.03.032_bib149","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/1091581813492829","article-title":"Using immunotoxicity information to improve cancer risk assessment for polycyclic aromatic hydrocarbon mixtures","volume":"32","author":"Zaccharia","year":"2013","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.032_bib150","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/bi00351a005","article-title":"Biosynthesis of cyclosporin A: partial purification and properties of a multifunctional enzyme from Tolypocladium inflatum","volume":"25","author":"Zocher","year":"1986","journal-title":"Biochemistry"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915002472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915002472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T07:05:20Z","timestamp":1691564720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915002472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":150,"alternative-id":["S0014299915002472"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.032","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The transferability from rat subacute 4-week oral toxicity study to translational research exemplified by two pharmaceutical immunosuppressants and two environmental pollutants with immunomodulating properties","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}